(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are AGBA Acquisition Limited, Wheeler Real Estate Investment Trust, and Riot Blockchain.

The three biggest losers today are SmileDirectClub, Artelo Biosciences, and Aesthetic Medical International Holdings Group Ltd..

Winners today

1. AGBA Acquisition Limited (AGBAW) – 55.26%

AGBA Group Holding Limited focuses on operating a full-service platform to banks, other financial institutions, brokers, and individual financial advisors to advise and serve its retail clients. The company offers a range of financial products, such as life insurance, pensions, property-casualty insurance, mutual funds, money lending, and real estate agency services. It also operates an health and wealth management platform that offers a range of services and value-added information in health, insurance, investments, and social sharing. The company is based in Wan Chai, Wan Chai.

NASDAQ ended the session with AGBA Acquisition Limited jumping 55.26% to $0.03 on Monday while NASDAQ rose 0.67% to $13,307.77.

Yearly Top and Bottom Value

AGBA Acquisition Limited’s stock is valued at $0.03 at 17:32 EST, higher than its 52-week high of $0.03.

More news about AGBA Acquisition Limited.

2. Wheeler Real Estate Investment Trust (WHLR) – 12.71%

Headquartered in Virginia Beach, VA, Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR ) is a fully integrated, self-managed commercial real estate investment company focused on owning and operating income-producing retail properties with a primary focus on grocery-anchored centers.

NASDAQ ended the session with Wheeler Real Estate Investment Trust jumping 12.71% to $3.28 on Monday, following the last session’s upward trend. NASDAQ rose 0.67% to $13,307.77, after three sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Wheeler Real Estate Investment Trust has a trailing twelve months EPS of $-20.06.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.59%.

More news about Wheeler Real Estate Investment Trust.

3. Riot Blockchain (RIOT) – 8.09%

Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.

NASDAQ ended the session with Riot Blockchain jumping 8.09% to $10.09 on Monday while NASDAQ rose 0.67% to $13,307.77.

Earnings Per Share

As for profitability, Riot Blockchain has a trailing twelve months EPS of $-1.58.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.82%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 16.7% and positive 71.1% for the next.

Volume

Today’s last reported volume for Riot Blockchain is 25962300 which is 24.78% above its average volume of 20805600.

Moving Average

Riot Blockchain’s worth is way under its 50-day moving average of $12.92 and higher than its 200-day moving average of $10.07.

More news about Riot Blockchain.

4. XTL Biopharmaceuticals Ltd. (XTLB) – 7.5%

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. XTL Biopharmaceuticals Ltd. has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.

NASDAQ ended the session with XTL Biopharmaceuticals Ltd. rising 7.5% to $1.00 on Monday while NASDAQ rose 0.67% to $13,307.77.

Earnings Per Share

As for profitability, XTL Biopharmaceuticals Ltd. has a trailing twelve months EPS of $-0.44.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -68.88%.

Moving Average

XTL Biopharmaceuticals Ltd.’s value is above its 50-day moving average of $0.92 and way below its 200-day moving average of $1.16.

Earnings Before Interest, Taxes, Depreciation, and Amortization

XTL Biopharmaceuticals Ltd.’s EBITDA is -8.22.

More news about XTL Biopharmaceuticals Ltd..

5. Abeona Therapeutics (ABEO) – 7.12%

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-5OX for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in New York, New York.

NASDAQ ended the session with Abeona Therapeutics rising 7.12% to $4.21 on Monday while NASDAQ jumped 0.67% to $13,307.77.

Earnings Per Share

As for profitability, Abeona Therapeutics has a trailing twelve months EPS of $-2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -267.17%.

Yearly Top and Bottom Value

Abeona Therapeutics’s stock is valued at $4.21 at 17:32 EST, way below its 52-week high of $5.80 and way above its 52-week low of $2.19.

Moving Average

Abeona Therapeutics’s value is way higher than its 50-day moving average of $3.72 and way above its 200-day moving average of $3.26.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Abeona Therapeutics’s EBITDA is -3.41.

Revenue Growth

Year-on-year quarterly revenue growth grew by 250%, now sitting on 3.57M for the twelve trailing months.

More news about Abeona Therapeutics.

6. Aethlon Medical (AEMD) – 7.01%

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

NASDAQ ended the session with Aethlon Medical rising 7.01% to $0.23 on Monday while NASDAQ jumped 0.67% to $13,307.77.

Earnings Per Share

As for profitability, Aethlon Medical has a trailing twelve months EPS of $-0.55.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -88.52%.

More news about Aethlon Medical.

7. Aeglea BioTherapeutics (AGLE) – 6.89%

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria. In addition, the company's preclinical pipeline includes cystinuria and research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.

NASDAQ ended the session with Aeglea BioTherapeutics jumping 6.89% to $12.25 on Monday while NASDAQ rose 0.67% to $13,307.77.

Earnings Per Share

As for profitability, Aeglea BioTherapeutics has a trailing twelve months EPS of $-76.76.

Yearly Top and Bottom Value

Aeglea BioTherapeutics’s stock is valued at $12.25 at 17:32 EST, way below its 52-week high of $39.00 and way higher than its 52-week low of $2.66.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 1.23M for the twelve trailing months.

More news about Aeglea BioTherapeutics.

8. Discover Financial Services (DFS) – 5.81%

Discover Financial Services, through its subsidiaries, provides digital banking products and services, and payment services in the United States. It operates in two segments, Digital Banking and Payment Services. The Digital Banking segment offers Discover-branded credit cards to individuals; private student loans, personal loans, home loans, and other consumer lending; and direct-to-consumer deposit products comprising savings accounts, certificates of deposit, money market accounts, IRA certificates of deposit, IRA savings accounts and checking accounts, and sweep accounts. The Payment Services segment operates the PULSE, an automated teller machine, debit, and electronic funds transfer network; and Diners Club International, a payments network that issues Diners Club branded charge cards and/or provides card acceptance services, as well as offers payment transaction processing and settlement services. The company was incorporated in 1960 and is based in Riverwoods, Illinois.

NYSE ended the session with Discover Financial Services jumping 5.81% to $91.66 on Monday, after two successive sessions in a row of gains. NYSE dropped 1.09% to $15,230.01, following the last session’s downward trend on what was an all-around negative trend trading session today.

Earnings Per Share

As for profitability, Discover Financial Services has a trailing twelve months EPS of $14.47.

PE Ratio

Discover Financial Services has a trailing twelve months price to earnings ratio of 6.33. Meaning, the purchaser of the share is investing $6.33 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.42%.

Volume

Today’s last reported volume for Discover Financial Services is 5069030 which is 112.67% above its average volume of 2383490.

Previous days news about Discover Financial Services

• Rosen, leading investor counsel, encourages discover financial services investors with losses in excess of $100k to secure counsel before important deadline in securities class action – DFS. According to Business Insider on Sunday, 1 October, "WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Discover Financial Services (NYSE: DFS) between February 21, 2019 and August 14, 2023, both dates inclusive (the "Class Period") of the important October 31, 2023 lead plaintiff deadline."

More news about Discover Financial Services.

9. Super Micro Computer (SMCI) – 5.2%

Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally. Its solutions range from complete server, storage systems, modular blade servers, blades, workstations, full racks, networking devices, server sub-systems, server management software, and security software. The company provides application-optimized server solutions, rackmount and blade servers, storage, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and technical documentation, and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company was incorporated in 1993 and is headquartered in San Jose, California.

NASDAQ ended the session with Super Micro Computer jumping 5.2% to $288.47 on Monday while NASDAQ rose 0.67% to $13,307.77.

Earnings Per Share

As for profitability, Super Micro Computer has a trailing twelve months EPS of $11.63.

PE Ratio

Super Micro Computer has a trailing twelve months price to earnings ratio of 24.8. Meaning, the purchaser of the share is investing $24.8 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.67%.

More news about Super Micro Computer.

10. Geo Group (GEO) – 5.01%

The GEO Group, Inc. (NYSE: GEO) is a leading diversified government service provider, specializing in design, financing, development, and support services for secure facilities, processing centers, and community reentry centers in the United States, Australia, South Africa, and the United Kingdom. GEO's diversified services include enhanced in-custody rehabilitation and post-release support through the award-winning GEO Continuum of Care, secure transportation, electronic monitoring, community-based programs, and correctional health and mental health care. GEO's worldwide operations include the ownership and/or delivery of support services for 102 facilities totaling approximately 82,000 beds, including idle facilities and projects under development, with a workforce of up to approximately 18,000 employees.

NYSE ended the session with Geo Group jumping 5.01% to $8.59 on Monday, after four successive sessions in a row of gains. NYSE dropped 1.09% to $15,230.01, following the last session’s downward trend on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, Geo Group has a trailing twelve months EPS of $0.96.

PE Ratio

Geo Group has a trailing twelve months price to earnings ratio of 8.95. Meaning, the purchaser of the share is investing $8.95 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.93%.

Volume

Today’s last reported volume for Geo Group is 3252430 which is 60.43% above its average volume of 2027250.

More news about Geo Group.

Losers Today

1. SmileDirectClub (SDC) – -66.24%

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.

NASDAQ ended the session with SmileDirectClub falling 66.24% to $0.14 on Monday, following the last session’s downward trend. NASDAQ rose 0.67% to $13,307.77, after three consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.628.

Sales Growth

SmileDirectClub’s sales growth is 10.4% for the present quarter and 26.5% for the next.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 55.6% and 61.1%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

SmileDirectClub’s EBITDA is -30.3.

More news about SmileDirectClub.

2. Artelo Biosciences (ARTLW) – -20.5%

NASDAQ ended the session with Artelo Biosciences falling 20.5% to $0.04 on Monday, after five successive sessions in a row of losses. NASDAQ rose 0.67% to $13,307.77, after three successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Yearly Top and Bottom Value

Artelo Biosciences’s stock is valued at $0.04 at 17:32 EST, higher than its 52-week high of $0.04.

More news about Artelo Biosciences.

3. Aesthetic Medical International Holdings Group Ltd. (AIH) – -12.35%

Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 28 treatment centers in China, Hong Kong, and Singapore. The company was founded in 1997 and is headquartered in Shenzhen, China.

NASDAQ ended the session with Aesthetic Medical International Holdings Group Ltd. falling 12.35% to $0.71 on Monday, following the last session’s downward trend. NASDAQ jumped 0.67% to $13,307.77, after three successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Aesthetic Medical International Holdings Group Ltd. has a trailing twelve months EPS of $-0.4.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Aesthetic Medical International Holdings Group Ltd.’s EBITDA is -5.62.

Volume

Today’s last reported volume for Aesthetic Medical International Holdings Group Ltd. is 53 which is 99.24% below its average volume of 6996.

Sales Growth

Aesthetic Medical International Holdings Group Ltd.’s sales growth is 120.3% for the current quarter and 23% for the next.

More news about Aesthetic Medical International Holdings Group Ltd..

4. NextEra Energy (NEE) – -11.21%

NextEra Energy, Inc., through its subsidiaries, generates, transmits, distributes, and sells electric power to retail and wholesale customers in North America. The company generates electricity through wind, solar, nuclear, coal, and natural gas facilities. It also develops, constructs, and operates long-term contracted assets that consists of clean energy solutions, such as renewable generation facilities, battery storage projects, and electric transmission facilities; sells energy commodities; and owns, develops, constructs, manages and operates electric generation facilities in wholesale energy markets. As of December 31, 2022, the company had approximately 32,100 megawatts of net generating capacity; approximately 88,000 circuit miles of transmission and distribution lines; and 871 substations. It serves approximately 12 million people through approximately 5.8 million customer accounts in the east and lower west coasts of Florida. The company was formerly known as FPL Group, Inc. and changed its name to NextEra Energy, Inc. in 2010. NextEra Energy, Inc. was founded in 1925 and is headquartered in Juno Beach, Florida.

NYSE ended the session with NextEra Energy sliding 11.21% to $50.87 on Monday, following the last session’s upward trend. NYSE slid 1.09% to $15,230.01, following the last session’s downward trend on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, NextEra Energy has a trailing twelve months EPS of $4.05.

PE Ratio

NextEra Energy has a trailing twelve months price to earnings ratio of 12.56. Meaning, the purchaser of the share is investing $12.56 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.5%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

NextEra Energy’s EBITDA is 46.03.

Volume

Today’s last reported volume for NextEra Energy is 36623100 which is 303.53% above its average volume of 9075490.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Aug 28, 2023, the estimated forward annual dividend rate is 1.87 and the estimated forward annual dividend yield is 3.28%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NextEra Energy’s stock is considered to be overbought (>=80).

More news about NextEra Energy.

5. Beam Therapeutics (BEAM) – -10.6%

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of refractory T-cell acute lymphoblastic leukemia/T cell lymphoblastic lymphoma; BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a; and BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease; and the Institute of Molecular and Clinical Ophthalmology Basel for treatment of impaired vision and blindness. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.

NASDAQ ended the session with Beam Therapeutics dropping 10.6% to $21.50 on Monday while NASDAQ rose 0.67% to $13,307.77.

Earnings Per Share

As for profitability, Beam Therapeutics has a trailing twelve months EPS of $-4.47.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.01%.

More news about Beam Therapeutics.

6. Amicus Therapeutics (FOLD) – -9.46%

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

NASDAQ ended the session with Amicus Therapeutics dropping 9.46% to $11.01 on Monday, following the last session’s upward trend. NASDAQ jumped 0.67% to $13,307.77, after three successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Amicus Therapeutics has a trailing twelve months EPS of $-0.66.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -130.04%.

More news about Amicus Therapeutics.

7. Plug Power (PLUG) – -9.28%

Plug Power Inc. delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road electric vehicles, stationary power market, and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem, including liquid green hydrogen production, storage and handling, transportation, and dispensing infrastructure. The company offers GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors. It also provides GenKey, an integrated turn-key solution for transitioning to fuel cell power; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; Liquefaction systems; and Electrolyzers that are hydrogen generators optimized for clean hydrogen production. The company sells its products through a direct product sales force, original equipment manufacturers, and dealer networks. Plug Power Inc. was founded in 1997 and is headquartered in Latham, New York.

NASDAQ ended the session with Plug Power falling 9.28% to $6.89 on Monday while NASDAQ jumped 0.67% to $13,307.77.

Earnings Per Share

As for profitability, Plug Power has a trailing twelve months EPS of $-1.44.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.73%.

Sales Growth

Plug Power’s sales growth is 38.5% for the ongoing quarter and 118.3% for the next.

Yearly Top and Bottom Value

Plug Power’s stock is valued at $6.89 at 17:32 EST, under its 52-week low of $7.27.

More news about Plug Power.

8. Aqua Metals (AQMS) – -8.85%

Aqua Metals, Inc. engages in the recycling of lead primarily in the United States. It produces and sells hard lead, lead compounds, and plastics. The company was incorporated in 2014 and is headquartered in McCarran, Nevada.

NASDAQ ended the session with Aqua Metals dropping 8.85% to $1.03 on Monday while NASDAQ jumped 0.67% to $13,307.77.

Earnings Per Share

As for profitability, Aqua Metals has a trailing twelve months EPS of $-0.22.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -83.13%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Aqua Metals’s EBITDA is -25.02.

Volume

Today’s last reported volume for Aqua Metals is 350021 which is 49.08% below its average volume of 687479.

More news about Aqua Metals.

9. Ebix (EBIX) – -8.4%

Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.

NASDAQ ended the session with Ebix sliding 8.4% to $9.05 on Monday, after four sequential sessions in a row of losses. NASDAQ jumped 0.67% to $13,307.77, after three successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Ebix has a trailing twelve months EPS of $1.09.

PE Ratio

Ebix has a trailing twelve months price to earnings ratio of 8.3. Meaning, the purchaser of the share is investing $8.3 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.64%.

Moving Average

Ebix’s value is way under its 50-day moving average of $17.79 and way under its 200-day moving average of $18.62.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ebix’s stock is considered to be overbought (>=80).

Revenue Growth

Year-on-year quarterly revenue growth declined by 52.8%, now sitting on 874.3M for the twelve trailing months.

More news about Ebix.

10. Nikola (NKLA) – -8.39%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola sliding 8.39% to $1.44 on Monday while NASDAQ jumped 0.67% to $13,307.77.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -132.55%.

Sales Growth

Nikola’s sales growth is 6.2% for the current quarter and 923% for the next.

More news about Nikola.

Stay up to date with our winners and losers daily report